MedTrace Logo

Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.

NCT01276002 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-07-06

No results posted yet for this study

Summary

The disruption of the pancreatic duct seems to be a major cause pseudocyst formation and persistence in patients suffering from acute/chronic pancreatitis. No prospective randomized studies have been conducted on the influence of pancreatic duct stenting for the patients' benefits and recurrence rates. The aim fo this study is therefore to evaluate prospectively in a randomized, controlled fashion in patients wit pancreatic pseudocysts, wether pancreatic duct stenting of a disrupted pancreatic duct is beneficial in terms of quicker clinical recovery and avoidance of recurrence of pancreatic pseudocysts.

Conditions

  • Chronic Acute Pancreatitis

Interventions

PROCEDURE

pancreatic duct stenting

in case of a disrupted pancreatic duct, patients will undergo pancreatic duct stenting.

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    lead OTHER

Principal Investigators

  • Mark Ellrichmann, MD · Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Germany

  • Annette Fritscher-Ravens, MD, PhD · Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01276002 on ClinicalTrials.gov